ABBOTT LABORATORIES (ABT)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Robert B. Ford Chairman of the Board and Chief Executive Officer | 2025 | $1,500,000 | $0 | $8,787,378 | $8,788,430 | $1,968,750 | $959,798 | $23,173,052 |
| 2024 | $1,500,000 | $0 | $8,226,593 | $8,227,441 | $2,861,250 | $618,998 | $22,591,322 | |
| 2023 | $1,500,000 | $0 | $7,436,600 | $7,437,649 | $2,945,250 | $283,392 | $20,373,964 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer | 2025 | $974,231 | $0 | $3,045,935 | $3,046,350 | $1,055,400 | $74,418 | $8,250,640 |
| 2024 | $884,039 | $0 | $2,693,071 | $2,693,336 | $1,224,700 | $74,748 | $7,597,619 | |
| 2023 | $513,943 | $0 | $786,041 | $786,272 | $583,500 | $44,083 | $2,727,268 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices | 2025 | $924,231 | $0 | $2,543,989 | $2,544,364 | $1,283,400 | $178,953 | $7,631,875 |
| 2024 | $879,269 | $0 | $2,016,528 | $2,016,819 | $1,249,200 | $130,047 | $6,444,774 | |
| 2023 | $737,654 | $0 | $1,684,197 | $1,684,477 | $904,900 | $85,380 | $5,196,818 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Hubert L. Allen Former Executive Vice President, General Counsel and Secretary | 2025 | $524,019 | $0 | $2,095,392 | $2,095,609 | $447,500 | $653,224 | $6,576,450 |
| 2024 | $911,154 | $0 | $2,095,395 | $2,095,609 | $1,094,700 | $540,170 | $7,527,867 | |
| 2023 | $830,000 | $0 | $1,959,639 | $1,959,993 | $941,700 | $228,916 | $6,491,684 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Daniel G. Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products | 2025 | $924,231 | $0 | $2,238,786 | $2,239,049 | $388,200 | $212,501 | $6,252,557 |
| 2024 | $879,269 | $0 | $1,833,239 | $1,833,495 | $855,400 | $157,015 | $5,789,762 | |
| 2023 | $790,000 | $0 | $1,880,183 | $1,880,493 | $880,300 | $91,977 | $5,662,042 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Christopher J. Scoggins Executive Vice President, Diabetes Care | 2025 | $859,502 | $0 | $1,662,503 | $1,662,743 | $1,095,300 | $108,443 | $5,472,142 |